Nov 16, 2020 6:55 am EST Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
Oct 1, 2020 4:30 pm EDT Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM
Sep 16, 2020 6:55 am EDT Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
Sep 11, 2020 7:00 am EDT Acasti Announces Filing and Mailing of Information Circular and Change in Record Date